BIO Continues To Mull PhRMA’s Marketing Code
This article was originally published in The Pink Sheet Daily
Executive Summary
Limits on physician interactions might not be appropriate when trying to educate doctors on complex, large-molecule products, the biotech group believes.
You may also be interested in...
Open Source Marketing: BIO Urges Members To Adopt PhRMA’s Code
The Biotechnology Industry Organization has adopted a broad policy statement that embraces the PhRMA marketing code that it initially had trepidations about
Open Source Marketing: BIO Urges Members To Adopt PhRMA’s Code
The Biotechnology Industry Organization has adopted a broad policy statement that embraces the PhRMA marketing code that it initially had trepidations about
Open Source Marketing: BIO Urges Members To Adopt PhRMA’s Code
Biotechnology group encouraged member firms to adopt the PhRMA Code, “tailored as appropriate” to own “particular circumstances.”